Your browser doesn't support javascript.
loading
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells.
Yao, Leyi; Zhao, Qian; Yan, Ding; Lei, Ziying; Hao, Yali; Chen, Jinghong; Xue, Qian; Li, Xiaofen; Huang, Qingtian; Tang, Daolin; Dou, Q Ping; Chen, Xin; Liu, Jinbao.
Afiliação
  • Yao L; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Zhao Q; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • Yan D; Institute of Digestive Disease of Guangzhou Medical University, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Qingyuan 511518, China.
  • Lei Z; School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
  • Hao Y; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Chen J; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • Xue Q; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Li X; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Huang Q; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • Tang D; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • Dou QP; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Chen X; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Disease, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • Liu J; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.
Cancer Biol Med ; 2022 May 24.
Article em En | MEDLINE | ID: mdl-35604090

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article